Professor David Johnson

MB BS (Hons), (Qld), PhD (Syd), DMed (Res), FASN, FRACP

Director, Metro South and Ipswich Nephrology and Transplant Service (MINTS)

About me

DAVID JOHNSON PSM

MB BS (Hons) (Qld), PhD (Syd), DMed(Res), FASN, FRACP

Email: [email protected]Address: ARTS Building, Princess Alexandra Hospital

 

David Johnson is currently Director of the Metro South and Ipswich Nephrology and Transplant Service (MINTS) and Medical Director of the Queensland Renal Transplant Service at Princess Alexandra Hospital, Brisbane, Australia, Professor of Medicine and Professor of Population Health at University of Queensland, Chair of the CARI Guidelines Working Parties on Peritoneal Dialysis Adequacy, Evaluation of Renal Function and Management of Early CKD, Chair of the Kidney Check Australia Taskforce, Co-Chair of the Australasian Creatinine and eGFR Consensus Working Party, Co-Chair of the Australasian Proteinuria Consensus Working Party, Founding Member and Deputy Chair of the Australasian Kidney Trials Network (based at Princess Alexandra Hospital), Founding Member of the NHMRC-endorsed Cardiovascular and Renal Centre of Clinical Research Excellence (CCRE), Member of the ANZDATA Registry Peritoneal Dialysis Working Group, International Society of Peritoneal Dialysis Councillor and International Society of Nephrology Councillor. He was Chair of the Queensland Statewide Renal Clinical Network from 2008 until 2013.

 

He is the principal investigator on a number of large, multi-centre randomised controlled trials, including the balANZ, HERO, IDEAL, IMPENDIA, HONEYPOT and CKD-FIX trials, and is chair of the Data Safety and Monitoring Board for the FINESSE trial. He has published over 560 original manuscripts in peer-reviewed journals and presented over 350 abstracts at national and international scientific meetings. He has won numerous research awards for his clinical and basic science studies in the areas of peritoneal dialysis outcomes, cardiovascular risk factor modification in uraemia, renal transplantation, dialysis unit infection control, treatment of acute renal failure and mechanisms of progressive chronic kidney disease. In 2005, he was awarded the TJ Neale Award by the Australian and New Zealand Society of Nephrology for "outstanding contributions to nephrologic science." He was a Queensland finalist in the Australian of the Year Awards for 2009. On Australia Day 2011, he was awarded a Public Service Medal by the Governor-General of Australia for outstanding public service, particularly research into the early detection and management of kidney disease. In 2014, he was awarded an International Distinguished Medal by the US National Kidney Foundation.

Projects

PI on balANZ, IDEAL, HERO, AVATAR, IMPENDIA and HONEYPOT trials

Research fields

Peritoneal Dialysis Outcomes, Cardiovascular Risk Factor Modification in Uraemia, Renal Transplantation, Dialysis Unit Infection Control, treatment of acute renal failure and mechanisms of progressive chronic kidney disease.